{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:5819",
      "entity_text" : "thyroxine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-1047" ],
      "Organ" : [ "uberon:UBERON:0007023" ]
    }
  },
  "verbose_text" : "In a recent double-blind, randomised, placebo controlled trial involving 737 adults who were at least 65 years of age (mean 74.4 years) and who had persisting subclinical hypothyroidism (TSH level 4.60 to 19.99 mIU/l; free thyroxine level within the reference range), no apparent benefits in alleviation of symptoms were obtained during one-year observation [XREF_BIBR].",
  "reading_complete" : "2020-08-03T18:07:51Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T18:04:20Z",
  "trigger" : "level",
  "evidence" : [ "thyroxine level" ],
  "pmc_id" : "5509968",
  "score" : 0
}